口腔薄膜市場規模、佔有率、成長分析（按產品、適應症、分銷管道和地區）- 產業預測，2025-2032 年

2023 年全球口腔薄膜市場規模為 34.6 億美元，預計將從 2024 年的 37.8 億美元成長到 2032 年的 77 億美元，預測期間（2025-2032 年）的複合年成長率為 9.3%。

全球口腔薄膜市場已成為製藥業的關鍵領域，其特點是生產可溶解的條帶，以增強口服藥物傳輸。這些薄膜提供了一種方便的、以患者為中心的傳統錠劑和膠囊的替代品，提高了給藥的簡易性、劑量的準確性和患者的依從性，特別是對於兒科和老年人群。雖然對創新藥物輸送系統的需求正在推動市場成長，但複雜的製造流程、監管障礙以及來自既定劑型的競爭等挑戰仍然存在。然而，機會無所不在，包括個人化醫療、兒科護理、自我管理療法和營養保健品等應用領域的不斷擴大，使口腔薄膜成為不斷發展的醫療保健領域的關鍵參與者。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術進步

口腔薄膜市場按產品分類的規模

• 市場概況
• 舌下含片
• 即溶牙科/口腔膜

口腔薄膜市場規模（依適應症分類）

• 市場概況
• 思覺失調症
• 偏頭痛
• 鴉片類成癮
• 噁心和嘔吐
• 其他

口腔薄膜市場規模（依分銷通路分類）

• 市場概況
• 醫院藥房
• 零售藥局
• 網路藥局

口腔薄膜市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• Pfizer Inc.（USA）
• Novartis International AG（Switzerland）
• Merck & Co., Inc.（USA）
• Sanofi SA（France）
• GlaxoSmithKline plc（UK）
• Johnson & Johnson（USA）
• Bayer AG（Germany）
• Eli Lilly and Company（USA）
• AbbVie Inc.（USA）
• AstraZeneca plc（UK）
• Sumitomo Dainippon Pharma Co., Ltd.（Japan）
• Indivior PLC（UK）
• BioDelivery Sciences International, Inc.（USA）
• Aquestive Therapeutics, Inc.（USA）
• IntelGenx Technologies Corp.（Canada）
• Tesa Labtec GmbH（Germany）
• CURE Pharmaceutical Holding Corp.（USA）
• ZIM Laboratories Limited（India）
• NAL Pharma（UK）

結論和建議

Global Oral Thin Films Market size was valued at USD 3.46 billion in 2023 and is poised to grow from USD 3.78 billion in 2024 to USD 7.7 billion by 2032, growing at a CAGR of 9.3% during the forecast period (2025-2032).

The global oral thin films market is emerging as a vital area of the pharmaceutical industry, characterized by the production of dissolvable strips that enhance oral drug delivery. These films offer a convenient and patient-centric alternative to traditional tablets and capsules, improving ease of administration, accurate dosage, and patient compliance, particularly for pediatric and geriatric populations. While the demand for innovative drug delivery systems propels market growth, challenges such as the complex manufacturing processes, regulatory hurdles, and competition from established dosage forms persist. Nevertheless, opportunities abound in personalized medicine, pediatric needs, and self-administered therapies, as well as expanding applications in the nutraceutical sector, positioning oral thin films as a significant player in the evolving healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Oral Thin Films market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Oral Thin Films Market Segmental Analysis

Global Oral Thin Films Market is segmented by Product, Disease Indication, Distribution Channel and region. Based on Product, the market is segmented into Sublingual Film and Fast Dissolving Dental/Buccal Film. Based on Disease Indication, the market is segmented into Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Oral Thin Films Market

A significant factor propelling the Global Oral Thin Films market is the rising patient preference for non-invasive drug delivery systems. In 2022, an increasing number of patients favored oral thin films over conventional oral medications like tablets and injections, appreciating their convenience and user-friendliness. The quick disintegration and ease of administration associated with these films enhance medication compliance, making them an attractive option for many. Additionally, the COVID-19 pandemic heightened awareness of safety in healthcare practices, further boosting the demand for non-invasive delivery methods. Consequently, the shift towards oral thin films as a preferred choice in medication delivery is becoming more pronounced.

Restraints in the Global Oral Thin Films Market

In 2022, one of the major obstacles impacting the global oral thin films market was the intricate manufacturing processes tied to these specialized dosage forms. The production and scaling of oral thin films necessitate advanced technology, specialized knowledge, and stringent quality assurance measures. This complexity not only raises manufacturing costs but also restricts the accessibility and affordability of oral thin films for consumers. As a result, these factors collectively pose challenges to market expansion, potentially stifling innovation and limiting the reach of these products in the healthcare sector. Consequently, addressing these manufacturing hurdles is crucial for fostering market growth.

Market Trends of the Global Oral Thin Films Market

The Global Oral Thin Films market is currently influenced by a notable trend characterized by the challenges posed by complex manufacturing processes. As of 2022, these intricate production requirements have emerged as a significant restraint, demanding advanced equipment and specialized expertise, thereby resulting in higher associated costs. This complexity hampers not only the scalability of oral thin films but also their affordability, potentially stunting market growth. Consequently, while there is a growing demand for innovative and convenient drug delivery systems, the barriers posed by manufacturing intricacies are prompting industry players to pursue technological advancements and streamlined processes to enhance production efficiency and market accessibility.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement

Global Oral Thin Films Market Size by Product & CAGR (2025-2032)

• Market Overview
• Sublingual Film
• Fast Dissolving Dental/Buccal Film

Global Oral Thin Films Market Size by Disease Indication & CAGR (2025-2032)

• Market Overview
• Schizophrenia
• Migraine
• Opioid Dependence
• Nausea & Vomiting
• Others

Global Oral Thin Films Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Oral Thin Films Market Size & CAGR (2025-2032)

• North America (Product, Disease Indication, Distribution Channel)
  • US
  • Canada
• Europe (Product, Disease Indication, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Disease Indication, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Disease Indication, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Disease Indication, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis International AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sumitomo Dainippon Pharma Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indivior PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioDelivery Sciences International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aquestive Therapeutics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IntelGenx Technologies Corp. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tesa Labtec GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CURE Pharmaceutical Holding Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZIM Laboratories Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NAL Pharma (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations